Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008;4(5):1043-60.
doi: 10.2147/vhrm.s3998.

Arterial pulmonary hypertension in noncardiac intensive care unit

Affiliations
Review

Arterial pulmonary hypertension in noncardiac intensive care unit

Mykola V Tsapenko et al. Vasc Health Risk Manag. 2008.

Abstract

Pulmonary artery pressure elevation complicates the course of many complex disorders treated in a noncardiac intensive care unit. Acute pulmonary hypertension, however, remains underdiagnosed and its treatment frequently begins only after serious complications have developed. Significant pathophysiologic differences between acute and chronic pulmonary hypertension make current classification and treatment recommendations for chronic pulmonary hypertension barely applicable to acute pulmonary hypertension. In order to clarify the terminology of acute pulmonary hypertension and distinguish it from chronic pulmonary hypertension, we provide a classification of acute pulmonary hypertension according to underlying pathophysiologic mechanisms, clinical features, natural history, and response to treatment. Based on available data, therapy of acute arterial pulmonary hypertension should generally be aimed at acutely relieving right ventricular (RV) pressure overload and preventing RV dysfunction. Cases of severe acute pulmonary hypertension complicated by RV failure and systemic arterial hypotension are real clinical challenges requiring tight hemodynamic monitoring and aggressive treatment including combinations of pulmonary vasodilators, inotropic agents and systemic arterial vasoconstrictors. The choice of vasopressor and inotropes in patients with acute pulmonary hypertension should take into consideration their effects on vascular resistance and cardiac output when used alone or in combinations with other agents, and must be individualized based on patient response.

Keywords: acute cor pulmonale; acute pulmonary hypertension; cor pulmonale; pulmonary hypertension; right heart failure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Therapeutic approach to arterial pulmonary hypertension in ICU. Abbreviations: CVP, central venous pressure; ECHO, echocardiogram; INO, inhaled nitric oxide; IV, intravenous; LVH, left ventricular hypertrophy; MAP, mean arterial pressure; PAC, pulmonary artery catheter; RV, right ventricle; RVH, right ventricular hypertrophy; SpO2, oxygen saturation in the blood; TV, tidal volume.

Similar articles

Cited by

References

    1. Adrie C, Holzmann A, Hirani WM, et al. Effects of intravenous Zaprinast and inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of acute respiratory distress syndrome. Anesthesiology. 2000;93:422–30. - PubMed
    1. Albertini M, Ciminaghi B, Mazzola S, et al. Improvement of respiratory function by bosentan during endotoxic shock in the pig. Prostaglandins Leukot Essent Fatty Acids. 2001;65:103–8. - PubMed
    1. Arafa OE, Geiran OR, Andersen K, et al. Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg. 2000;70:1587–93. - PubMed
    1. Atz AM, Wessel DL. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology. 1999;91:307–10. - PubMed
    1. Aubert S, Leprince P, Bonnet N, et al. Limited mechanical circulatory support following orthotopic heart transplantation. Interact Cardiovasc Thorac Surg. 2006;5:88–9. - PubMed

Publication types

Substances